Medication Therapy Management Benefits Act of 2009

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. S 510 - The Food Safety Modernization Act HR 3108 - Medication Therapy Management Benefits Act of 2009 S 3543 - Medication Therapy Management Expanded Benefits Act of 2010 PL 111-148 - The Patient Protection and Affordable Care Act; provisions related to provider screening and documentation for referral of DME PL 111-152 - Health Care and Education Reconciliation Act; provisions related to provider screening and documentation for referral of DME Implementation of the Medicare Provider Enrollment, Chain and Ownership System (PECOS) S 3397 - Secure & Responsible Drug Disposal Act of 2010 S 3454 - National Defense Authorization Act for Fiscal Year 2011; potential proposals related to TRICARE pharmacy co-payments PL 111-226; provisions related to AMP and Medicaid funding P.L. 111-286; The Physician Payment and Therapy Relief Act of 2010 PL 111-309; Medicare and Medicaid Extenders Act of 2010 HR 2647, National Defense Authorization Act for Fiscal Year 2010

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and rust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market Access Act of 2009. S.511, Access to Durable Medical Equipment Act. S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $110,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation affecting retail pharmacies. H.R. 3108/S. 3543, Medication Therapy Management Benefits Act of 2009.

Client expense: Not reported · Firm income: $30,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

pension preservation & savings expansion acat 2003 H.R. 1776/S.2264/S.2233/H.R. 3108 employee retirment security action of 1974 H.R. 525/S.406 pension system overhaul-multi employer pension fund reform H.R. 2830 pension reform bills H.R. 280/S.1783 pension bill H.R. 2830/H.R. 4/S. 1783 Prevention of Access to Care for Medicare Beneficires & Pension Relief Act of 2010 - H.R. 3962

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590- the "Patient Protection and Affordable Care Act" regarding the role of pharmacists and the practice of pharmacy in healthcare. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1586- the "FAA Air Transportation Modernization and Safety Improvement Act" -Title II- all provisions relating to State Fiscal Relief and other provisions. Extend through the first three quarters of 2011 the Federal Medicaid Assistance Percentage (FMAP). Amend title XIX of the Social Security Act to include Medicaid coverage in the Medicaid average manufacturer price any drug that is an inhalation, infusion, instilled, implanted, or injectable drug that is not generally dispensed through a retail pharmacy. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 5597 - all provisions regarding establishing a Medicare patient IVIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP).

Client expense: $340,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Centers for Medicare and Medicaid Services: CMS-6010-IFC - Interim Final Rule with Comment Period: Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements House Leadership: HR3108, sent letter in support of Medication Therapy Benefits Act FDA - Comments submitted (9/7/10) to Docket # FDA-2010-N-0001 for meeting of the FDA Drug Safety & risk Management Advisory Committee: Dextromethorphan HHS - Comments submitted (9/13/10) to Modifications to the HIPAA Privacy, Security and Enforcement Rules under the HITECH Act. Agency for Healthcare Research & Quality (AHRQ) - signed on to coalition letter (8/30/10) supporting research questions submitted by PQA regarding Medication Therapy Management Services. CMS - signed on to coalition letter (8/6/10) regarding RFP on Retail Survey Price issued by CMS.

Client expense: $214,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Bureau of Investigation (FBI), Federal Reserve System, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, Treasury, Dept of

H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market ccess Act of 2009. S.511, Access to Durable Medical Equipment Act S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S 3543 - Medication Therapy Management Expanded Benefits Act of 2010 HR 3108 - Medication Therapy Management Benefits Act of 2009 Under Line 17: We would like to include the Dept of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC) HR 5389 - Medicare Clinical Pharmacist Practitioner Services Coverage Act of 2010 HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act (Public Law 111-148) - Patient Protection and Affordable Care Act [Sections on long-term care pharmacy waste reduction programs, CMS Innovation Center, and pharmacists participation in Accountable Care Organizations (ACOs)] (Docket Number: CMS6010IFC) Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements (Docket Number: CMS-2238-P2) Medicaid Program; Withdrawal of Determination of Average Manufacturer Price, Multiple Source Drug Definition, and Upper Limits for Multiple Source Drugs (Docket Number: CMS-6028-P) Medicare, Medicaid, and Children's Health Insurance Programs; Additional Screening Requirements, Application Fees, Temporary Enrollment Moratoria, Payment Suspensions and Compliance Plans for Providers and Suppliers (RIN 0991-AB58) Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology; Final Rule (Docket Number: CMS-0033-F) Medicare and Medicaid Programs; Electronic Health Record Incentive Program (Docket Number: CMS0023IFC) Medicare Program; Identification of Backward Compatible Version of Adopted Standard for EPrescribing and the Medicare Prescription Drug Program (NCPDP SCRIPT 10.6) CMS May 21, 2010 Memorandum to Medicare Part D Sponsors on revised guidance for implementing the Medicare Coverage Gap Discount Program CMS Medicare Part D Coverage Gap Discount Program - Manufacturer Agreements CMS September 10, 2010 Memorandum on Additional Guidance concerning Closing the Coverage Gap in 2011 CMS: Letter on Implementation of Retail Survey Price under the Deficit Reduction Act and the Patient Protection and Affordable Care Act (P.L. 111-148) - August 6, 2010

Client expense: $212,859 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification from the Department of Treasury regarding the new "over the counter" rules with Flexible Spending Accounts (FSA).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. S 510 - The Food Safety Modernization Act HR 3108 - Medication Therapy Management Benefits Act of 2009 S 3543 - Medication Therapy Management Expanded Benefits Act of 2010 PL 111-148 - The Patient Protection and Affordable Care Act; provisions related to provider screening and documentation for referral of DME PL 111-152 - Health Care and Education Reconciliation Act; provisions related to provider screening and documentation for referral of DME Implementation of the Medicare Provider Enrollment, Chain and Ownership System (PECOS) S 3397 - Secure & Responsible Drug Disposal Act of 2010 S 3454 - National Defense Authorization Act for Fiscal Year 2011; potential proposals related to TRICARE pharmacy co-payments PL 111-226; provisions related to AMP and Medicaid funding

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $240,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Centers for Medicare and Medicaid Services: CMS-6010-IFC - Interim Final Rule with Comment Period: Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements House Leadership: HR3108, sent letter in support of Medication Therapy Benefits Act CMS - provided comments to Internet-based Provider Enrollment, Chain Ownership System (PECOS) Senate Leadership: HR4213, asked for inclusion of an amendment that would provide for a six-month extension on the increased federal medical assistance percentage (until January 2011)

Client expense: $337,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Federal Bureau of Investigation (FBI), Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), SENATE, Treasury, Dept of

H.R. 1204, the Community Pharmacy Fairness Act of 2009 and S. 2191, the Community Pharmacy Fairness Act from the 110th Congress; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; H.R. 6331 (110th Congress), the Medicare Improvement for Patients and Providers Act of 2008-Sec. 172 related to the implementation of the Medciare Part D prompt pay requirements and submission of claims by pharmacies located in or contracting with long-term care facilities; H.R. 5235, the Medicare Access to Diabetic Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; H.R. 4213, the American Jobs and Closing Tax Loopholes Act of 2010-advocated for inclusion of the extension of the Federal Medicaid Matching Rate (FMAP) and limiting access to 340b drugs in outpatient settings to only eligible individuals in both House bill and Senate amendment; H.R. 5839 (110th Congress) the Safeguarding America's Pharmaceuticals Act of 2008, provisions related to pedigree and track and trace requirements-no bill introduced in the current Congress; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act , includes funding for the Department of Defense FY11 budget and covers the TRICARE pharmacy program; H.R. 3108 and S. 3543, the Medication Therapy Management Expanded Benefit Act; H.R. 2923, the Combat Meth Act of 2009; S. 1383, the Dextromethorphan Abuse Reduction Act of 2009; submitted comments to Senate Committee on Aging on prescription drug disposal and the role of nurses as agents in long-term care facilities; sought Congressional support to stop exclusion of certain retail pharmacies from "employee prescription drug plans;" worked with Congressional offices to request the FTC review the 180 day generic drug marketing exclusivity policies of certain generic manufacturers; sought Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); submitted comments to Senate Judiciary Committee regarding the FTC and DOJ antitrust oversight; submitted comments to Senate Homeland Security and Government Affairs Committee regarding a HHS OIG report, "Invalid Prescriber Identifiers on Medicare Part D Drug Claims;" FSA debit card program-seeking Congressional support to amend IRS guidance (no legislation).

Client expense: $106,568 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 4851, the "Continuing Extension Act of 2010," - section 4 - provisions relating to amending title XVIII (Medicare) of the Social Security Act to extend through May 31, 2010, the 0% update to the conversion factor in the Medicare physician payment computation. HR 5597 - all provisions regarding establishing a Medicare patient NIG access demonstration project. S. 3543 - the "Medication Therapy Management Expanded Benefits Act of 2010," - all provisions, regarding amending Part D of title XVIII of the Social Security Act to increase the number of diseases and conditions for which beneficiaries may be targeted for medication therapy management services. HR 4213 - the "American Jobs and Closing Tax Loopholes Act of 2010," - section 232 - regarding amending ARRA to extend through December 31, 2010, the increase in the Medicaid federal medical assistance percentage (FMAP). HR 3590 - the Patient Protection and Affordable Care Act.

Client expense: $350,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

HR 3108 - Medication Therapy Management Benefits Act of 2009 S 3543 - Medication Therapy Management Expanded Benefits Act of 2010 Under Line 17: We would like to include the Dept of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC) HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act (Public Law 111-148) - Patient Protection and Affordable Care Act (Sections on long-term care pharmacy waste reduction programs and pharmacists participation in Accountable Care Organizations (ACOs) (Docket Number: CMS-4085-F) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Docket Number: CMS6010IFC] Medicare and Medicaid Programs; Changes in Provider and Supplier Enrollment, Ordering and Referring, and Documentation Requirements; and Changes in Provider Agreements (Docket Number: CMS-0033-P) Medicare and Medicaid Programs; Electronic Health Record Incentive Program; Proposed Rule (Docket Number: RIN 0991-AB58) Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (Docket Number: RIN 0991AB59) Proposed Establishment of Certification Programs for Health Information Technology (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records (CAG-00420N) CMS Proposed Decision Memo for Counseling to Prevent Tobacco Use 2011 Preliminary Advanced Notice with Final Call Letter to Medicare Plans CMS April 30, 2010 Memorandum to Medicare Part D Sponsors on Draft guidance for implementing the Medicare Coverage Gap Discount Program CMS May 21, 2010 Memorandum to Medicare Part D Sponsors on revised guidance for implementing the Medicare Coverage Gap Discount Program

Client expense: $151,510 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Reconciliation Act of 2010 H.R. 616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R. 3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparancy, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S. 3532, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010.

Client expense: $420,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. S 510 - The Food Safety Modernization Act HR 3108 - Medication Therapy Management Benefits Act of 2009 PL 111-148 - The Patient Protection and Affordable Care Act; provisions related to provider screening and documentation for referral of DME PL 111-152 - Health Care and Education Reconciliation Act; provisions related to provider screening and documentation for referral of DME Implementation of the Medicare Provider Enrollment, Chain and Ownership System (PECOS)

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

pension preservation & savings expansion acat 2003 H.R. 1776/S.2264/S.2233/H.R. 3108 employee retirment security action of 1974 H.R. 525/S.406 pension system overhaul-multi employer pension fund reform H.R. 2830 pension reform bills H.R. 280/S.1783 pension bill H.R. 2830/H.R. 4/S. 1783 Prevention of Access to Care for Medicare Beneficires & Pension Relief Act of 2010 - H.R. 3962

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $433,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program.

Client expense: $350,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

HR 2718/S 1110 - MedPAC Reform Act of 2009 HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act Under Line 17: We would like to include the Dept of Health and Human Services' Office of the National Coordinator for Health Information Technology (ONC) and the Office of Inspector General (OIG) S 1634 - The Medicare Prescription Drug Improvement Act of 2009 S 266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR 203 - Medicare Fraud Prevention Act of 2009 HR 27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR 616/S 511 - Access to Durable Medical Equipment Act HR 574/S 254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR 2560/S 1131 - Independence At Home Act HR 1970/S 956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR 3700/S 1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR 3108 - Medication Therapy Management Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform S 683 - Community Choice Act of 2009 HR 1392/S 1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price S AMDT 3320 to the Commerce, Justice, Science, and Related Agencies Appropriations Act, 2010 (H.R.2847) [Section on the treatment of pharmacies under durable medical equipment accreditation requirements] (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) (Docket Number: CMS-0033-P) Medicare and Medicaid Programs; Electronic Health Record Incentive Program; Proposed Rule (Docket Number: RIN 0991-AB58) Health Information Technology: Initial Set of Standards, Implementation Specifications, and Certification Criteria for Electronic Health Record Technology (Docket Number: RIN 0991AB59) Proposed Establishment of Certification Programs for Health Information Technology (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter on NDC Non-Matched List 2011 Preliminary Advanced Notice with Draft Call Letter to Medicare Plans 2011 Preliminary Advanced Notice with Final Call Letter to Medicare Plans Draft Medicare Part D Model Notices for Beneficiaries: Mail-Order and Excluded Provider GAO Report on Medicaid Outpatient Prescription Drugs: Second Quarter 2008 Federal Upper Limits for Reimbursement Compared with Average Retail Pharmacy Acquisition Costs OIG Report on A Comparison of Medicaid Federal Upper Limit Amounts to Acquisition Costs, Medicare Payment Amounts, and Retail Prices

Client expense: $149,615 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office

H.R. 3108, Medication Therapy Management; H.R. 1970, Pharmacy and Optical Medicare Part B Surety Bond H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, The Helath Care and Education Affordablity Reconciliation Act

Client expense: $1,930,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Commerce, Dept of (DOC), Energy, Dept of, Environmental Protection Agency (EPA), Federal Energy Regulatory Commission (FERC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Natl Security Council (NSC), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), White House Office

H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and pharmacy benefit manager transparency requirements; H.R.3590: An act entitled The Patient Protection and Affordable Care ActDME Accreditation, AMP Fix, PBM Transparency, MTM Expansion, OPM PBA v. PBM; Senator Akaka Amendment to Senate version of H.R. 3590 to establish automatic enrollment into a Medicare Part D "chronic care management" program for targeted individuals; Senator Brown amendment to H.R. 3590 eliminating DMEPOS surety bond requirement for retail pharmacies; Senator Dorgan Drug Reimportation amendment to H.R. 3590; FSA Debit Card Programseeking Congressional support to amend IRS guidance (no legislation). P.L. 110-275, the Medicare Improvements for Patients and Providers Act of 2008, implementation of Part D prompt payment and Part B DMEPOS provisions; H.R. 4213, American Workers, State, and Business Relief Act of 2010, section 213, Medicare Part B DMEPOS accreditation requirements; H.R. 4872 and substitute amendment to H.R. 4872, the Health Care and Education Affordability Reconciliation Act of 2010, section 1101, the Medicare Part D "donut hole", section 1305, oversight of DMEPOS suppliers.

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), pharmacy dispensing fees, privacy, drug safety, and reimportation. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3200: America's Affordable Health Choices Act of 2009 HR 3590: The Patient Protection and Affordable Care Act HR 3962: Affordable Health Care for America Act S 1679: Affordable Health Choices Act S 1796: America's Healthy Future Act of 2009 HR 4872 - Health Care and Education Reconciliation Act of 2010 HR 3108 - Medication Therapy Management Benefits Act of 2009

Client expense: Not reported · Firm income: $50,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds.

Client expense: $470,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

pension preservation & savings expansion acat 2003 H.R. 1776/S.2264/S.2233/H.R. 3108 employee retirment security action of 1974 H.R. 525/S.406 pension system overhaul-multi employer pension fund reform H.R. 2830 pension reform bills H.R. 280/S.1783 pension bill H.R. 2830/H.R. 4/S. 1783

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $341,256 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3590, Patient Protection and Affordable Care Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $220,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

Client expense: $430,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

HR 2718/S 1110 - MedPAC Reform Act of 2009 HR 2307/S 1004 - Reaching Elders with Assessment and Chronic Care Management and Coordination Act S 1634 - The Medicare Prescription Drug Improvement Act of 2009 Under Line 17: We would like to include the Office of the National Coordinator for Health Information Technology S 266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR 203 - Medicare Fraud Prevention Act of 2009 HR 27 - Medicare Fraud Prevention and Enforcement Act of 2009 HR 616/S 511 - Access to Durable Medical Equipment Act HR 574/S 254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR 2560/S 1131 - Independence At Home Act HR 1970/S 956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR 3700/S 1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR 3108 - Medication Therapy Managament Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform HR 3663 - Amends the Social Security Act to delay the October 1, 2009 deadline on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies. (Public Law 111-72) S 683 - Community Choice Act of 2009 HR 1392/S 1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) (Docket No. CMS-4085-P) Medicare Program; Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs Docket Number: CMS-10260 (OMB#: 0938-1051) Collection Activities; Medicare Advantage and Prescription Drug Program: Final Marketing Provisions (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter Draft Part D Model Notices for Beneficiaries: Mail-Order and Excluded Provider

Client expense: $117,517 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office

H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3763: To amend the Fair Credit Reporting Act to provide for an exclusion from Red Flag Guidelines for certain businesses, pharmacy provision; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy management, public plan option and pharmacy benefit manager transparency requirements; H.R.3590: An act entitled The Patient Protection and Affordable Care ActDME Accreditation, AMP Fix, PBM Transparency, MTM Expansion, OPM PBA v. PBM; Senator Akaka Amendment to Senate version of H.R. 3590 to establish automatic enrollment into a Medicare Part D "chronic care management" program for targeted individuals; Senator Brown amendment to H.R. 3590 eliminating DMEPOS surety bond requirement for retail pharmacies; Senator Dorgan Drug Reimportation amendment to H.R. 3590; FSA Debit Card Programseeking Congressional support to amend IRS guidance (no legislation).

Client expense: $180,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Small Business Administration (SBA), Treasury, Dept of

H.R. 3590, Patient Protection and Affordable Care Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

pension preservation & savings expansion acat 2003 H.R. 1776/S.2264/S.2233/H.R. 3108 employee retirment security action of 1974 H.R. 525/S.406 pension system overhaul-multi employer pension fund reform H.R. 2830 pension reform bills H.R. 280/S.1783 pension bill H.R. 2830/H.R. 4/S. 1783

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1, the American Recovery and Reinvestment Act, as related to health information technology and state Medicaid programs. H.R. 1259, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan. H.R. 1427, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. S. 726, Promoting Innovation and Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals. H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. H.R.759, Food and Drug Administration Globalization Act of 2009, as related to the safety of prescription drugs. H.R. 1191/S.1336, Safe Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1256, the Family Smoking Prevention and Tobacco Control Act, as related to the importation of prescription drugs. H.R. 1298/S.525,S.1232, Pharmaceutical Market Access and Drug Safety Act, as related to the importation of prescription drugs. H.R. 1359, Secure and Responsible Drug Disposal Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 1450, Counterfeit Drug Prevention Act of 2009, as related to the prosecution of prohibited acts related to prescription drugs. H.R. 1548, Pathway for Biosimilars Act, as related to the approval of generic biopharmaceuticals by the FDA. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from the Medicare Bart B surety bond requirement. H.R. 2221, Data Accountability and Trust Act, related to the use of prescription drug data by pharmacies. H.R. 2552, Medical Waste Management Act of 2009, as related to the role of pharmacy in the disposal of prescription drugs. H.R. 2923/S.256, Combat Methamphetamine Enhancement Act, as related to the abuse of methamphetamine. H.R. 2997/S.1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010, as related to the importation of prescription drugs. H.R. 3108, the Medication Therapy Management Benefits Act, as related to an expanded MTM program in the Medicare Part D program. H.R. 3200, America's Affordable Health Choices Act of 2009, related to changes in pharmacy Medicaid reimbursement and the role of pharmacy and pharmacists in healthcare reform. H.R. 3590, Patient Protection and Affordable Care Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. H.R. 3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME Program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically related to Medicare and Medicaid issues. S.1383, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.

Client expense: $450,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office

H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: $281,205 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Health care reform proposals, provisions impacting employers. H1N1 preparedness. H.R. 3200, America's Affordable Health Choices Act of 2009. S. 1679, Affordable Health Choices Act. S. 956/H.R. 1970, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009. H.R. 3108, Medication Therapy Management Benefits Act of 2009.

Client expense: Not reported · Firm income: $100,000

Government targets: Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), Labor, Dept of (DOL), SENATE, Transportation, Dept of (DOT)

pension preservation & savings expansion acat 2003 H.R. 1776/S.2264/S.2233/H.R. 3108 employee retirment security action of 1974 H.R. 525/S.406 pension system overhaul-multi employer pension fund reform H.R. 2830 pension reform bills H.R. 280/S.1783 pension bill H.R. 2830/H.R. 4/S. 1783

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S.701/HR. 2002 the Medicare Patient IVIG Access Act of 2009 Section 4, provisions relating to coverage of home administration of IVIG and reimbursement for services, supplies and equipment. Pharmacy enhancements for consideration to the Medicare Modernization Act no specific legislation. HR. 1765 all provisions, regarding amending the Social Security Act with respect to payment for items and services relating to the furnishing of IVIG in a patients home for the treatment of primary immune deficiency disease and to cover certain disposable pumps as durable medical equipment in place of non-disposable pumps under the Medicare program. HR. 203 the Medicare Fraud Prevention Act of 2009 Section 4 provisions relating to the increased surety bond requirement of suppliers of durable medical equipment. S. 956/HR 1970 the Preserve Patient Access to Reputable DMEPOS Providers Act of 2009 all provisions; regarding exempting unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). HR 574/S. 254 the Medicare Home Infusion Therapy Act of 2009 all provisions; regarding amending the Social Security Act to provide for the coverage of home infusion therapy under the Medicare program. HR. 3108 the Medication Therapy Management Benefits Act of 2009, all provisions; regarding amending part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR. 3663 all provisions; regarding amending title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies.

Client expense: $370,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

S266 - Medicare Prescription Drug Gap Reduction Act of 2009 HR203 - Medicare Fraud Prevention Act of 2009 HR27 - Medicare Fraud Prevention and Enforcement Act of 2009 Under Line 17: We would like to include the Office of the National Coordinator for Health Information Technology HR616/S511 - Access to Durable Medical Equipment Act HR574/S254 - Medicare Home Infusion Therapy Coverage Act of 2009 HR2560/S1131 - Independence At Home Act HR1970/S956 - Preserve Patient Access to the Reputable DMEPOS Providers Act of 2009 HR3700/S1951 - Fair Medicaid Drug Payment Act (From 110th Congress)/Concept to Include Medicaid Average Manufacturers Price Reimbursement Formula in Health Care Reform HR3108 - Medication Therapy Managament Benefits Act of 2009/Concept to Include Medication Therapy Management Provisions in Health Care Reform HR3663 - Amends the Social Security Act to delay the October 1, 2009 deadline on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies. S683 - Community Choice Act of 2009 HR1392/S1221 - Amends the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price (Public Law 110-275) Medicare Improvements for Patients and Providers Act of 2008 sections on Medicare DMEPOS (Docket Number: CMS1561IFC) Medicare Program; Changes to the Competitive Acquisition of Certain Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) by Certain Provisions of the Medicare Improvements for Patients and Providers Act of 2008 (MIPPA) (Docket Number: CMS-1540-F) Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2007; Certain Provisions Concerning Competitive Acquisition for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS); Accreditation of DMEPOS Suppliers (Docket Number: CMS-6006-F) Medicare Program: Surety Bond Requirement for Suppliers of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) [Document Number: CMS-10260 (OMB#: 0938-1051)] Collection Activities; Medicare Advantage and Prescription Drug Program: Final Marketing Provisions (74 FR 45206) HRSA Notice Regarding 340B Pricing Program - Children's Hospitals (74 FR 28937) ONC Draft Recommendations for the Term "Meaningful Use" of Electronic Health Records CMS August 2009 Memo: Fraud, Waste and Abuse (FWA) Training Clarification (regarding changes to 42 C.F.R. 422.503(b)(4)(vi) and 42 C.F.R. 423.504 (b)(4)(vi)) Final 2010 Medicare Part D Call Letter

Client expense: $157,696 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Indian Health Service, SENATE, White House Office

H.R. 3200, America's Affordable Health Choices Act of 2009 America's Healthy Future Act H.R. 3108, Medication Therapy Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

All legislative and executive actions concerning healthcare reform, including provisions related to medication therapy management (MTM), average manufacturer's price (AMP), durable medical equipment (DME), and pharmacy dispensing fees. S 956 - A bill to amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) HR 1970 - To amend title XVIII of the Social Security Act to exempt unsanctioned State-licensed retail pharmacies from the surety bond requirement under the Medicare Program for suppliers of durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS). S 511 - A bill to amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 616 - To amend part B of title XVIII of the Social Security Act to provide for an exemption of pharmacies and pharmacists from certain Medicare accreditation requirements in the same manner as such exemption applies to certain professionals. HR 3108 - To amend part D of title XVIII of the Social Security Act to promote medication therapy management under the Medicare part D prescription drug program. HR 3200 -America's Affordable Health Choices Act of 2009 - Title IV Quality, Subtitle E Financing, Sec. 1741 Payments to Pharmacists, (a) Pharmacy Reimbursement Limits; Title II Workforce, Subtitle D Adapting Workforce to Evolving Health System Needs, Part 2 Interdisciplinary Training Programs, Sec. 2252 Innovations In Interdisciplinary Care Training, (b) Training Programs; Title III Promoting Primary Care, Mental Health Services, and Coordinated Care, Sec. 1302 Medical Home Pilot Program, (d) Community-Based Medical Home Model; Title I Improving Health Care Value, Subtitle B Provisions Related to Part B, Part 3 Other Provisions, Sec. 1148. Durable Medical Equipment Program Improvements Americas Healthy Future Act of 2009 - Title I Health Care Coverage, Subtitle G Role of Public Programs, Part V - Medicaid Prescription Drug Coverage, Changes to Medicaid Payment for Prescription Drugs; Title III Improving the Quality and Efficiency of Health Care, Part III Encouraging Development of the New Patient Care Models, CMS Innovation Center; Title III Improving the Quality and Efficiency of Health Care, Subtitle D Improving Payment Accuracy, Durable Medical Equipment S 1679 -Affordable Health Choices Act - Title II Improving the Quality and Efficiency of Health Care, Subtitle A National Strategy to Improve Health Care Quality, Sec. 213 Grants to Implement Medication Management Services in Treatment of Chronic Diseases; Title II - Improving the Quality and Efficiency of Health Care, Subtitle B Health Care Quality Improvements, Sec. 212 Grants to Establish Community Health Teams to Support the Patient-Centered Medical Home HR 3293 - Department of Health and Human Services Appropriations Act of 2010 - proposed inclusion of provisions relating to Durable Medical Equipment

Client expense: Not reported · Firm income: $40,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE